CorMedix IncNASDAQ:CRMD
- LAST PRICE9.9600
- TODAY'S CHANGE (%)-0.3700 (-3.5818%)
- Bid / Lots9.9200/ 10
- Ask / Lots10.0800/ 1
- Open / Previous Close10.3400 / 10.3300
- Day Range
- 52 Week Range
- Volume880,050
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 7141 | 10.37 |
| 09:33 ET | 11908 | 10.23 |
| 09:35 ET | 14105 | 10.24 |
| 09:37 ET | 1700 | 10.23 |
| 09:39 ET | 6865 | 10.3272 |
| 09:42 ET | 903 | 10.32 |
| 09:44 ET | 2528 | 10.33 |
| 09:46 ET | 922 | 10.34 |
| 09:48 ET | 1450 | 10.37 |
| 09:50 ET | 2166 | 10.3453 |
| 09:51 ET | 3476 | 10.27 |
| 09:53 ET | 600 | 10.27 |
| 09:55 ET | 2609 | 10.3369 |
| 09:57 ET | 4809 | 10.27 |
| 10:00 ET | 1286 | 10.2793 |
| 10:02 ET | 5506 | 10.1401 |
| 10:04 ET | 700 | 10.2 |
| 10:06 ET | 3700 | 10.1602 |
| 10:08 ET | 16228 | 10.16 |
| 10:09 ET | 5185 | 10.175 |
| 10:11 ET | 1060 | 10.195 |
| 10:13 ET | 1784 | 10.19 |
| 10:15 ET | 12926 | 10.185 |
| 10:18 ET | 5525 | 10.146 |
| 10:20 ET | 6370 | 10.16 |
| 10:22 ET | 100 | 10.155 |
| 10:24 ET | 2734 | 10.115 |
| 10:26 ET | 1585 | 10.16 |
| 10:27 ET | 2765 | 10.1 |
| 10:29 ET | 11885 | 10.05 |
| 10:31 ET | 8678 | 10.06 |
| 10:33 ET | 4338 | 10.0196 |
| 10:36 ET | 9968 | 10.1 |
| 10:38 ET | 1610 | 10.12 |
| 10:40 ET | 870 | 10.13 |
| 10:42 ET | 100 | 10.12 |
| 10:44 ET | 2214 | 10.125 |
| 10:45 ET | 1700 | 10.18 |
| 10:47 ET | 200 | 10.17 |
| 10:49 ET | 400 | 10.135 |
| 10:51 ET | 1429 | 10.12 |
| 10:54 ET | 10609 | 10.1128 |
| 10:56 ET | 3520 | 10.0801 |
| 10:58 ET | 180 | 10.054 |
| 11:02 ET | 1010 | 10.09 |
| 11:03 ET | 5500 | 10.1 |
| 11:05 ET | 5201 | 10.115 |
| 11:07 ET | 2200 | 10.12 |
| 11:09 ET | 300 | 10.12 |
| 11:12 ET | 100 | 10.1 |
| 11:16 ET | 300 | 10.105 |
| 11:18 ET | 100 | 10.105 |
| 11:20 ET | 100 | 10.08 |
| 11:21 ET | 100 | 10.13 |
| 11:23 ET | 528 | 10.11 |
| 11:25 ET | 835 | 10.14 |
| 11:27 ET | 1585 | 10.08 |
| 11:30 ET | 400 | 10.08 |
| 11:32 ET | 200 | 10.09 |
| 11:36 ET | 5515 | 10.03 |
| 11:39 ET | 700 | 10.08 |
| 11:41 ET | 1898 | 10.1 |
| 11:43 ET | 385 | 10.08 |
| 11:48 ET | 1783 | 10.08 |
| 11:50 ET | 201 | 10.12 |
| 11:52 ET | 333 | 10.1 |
| 11:54 ET | 6309 | 10.12 |
| 11:56 ET | 1372 | 10.1 |
| 11:57 ET | 1210 | 10.14 |
| 11:59 ET | 555 | 10.1365 |
| 12:01 ET | 1821 | 10.13 |
| 12:03 ET | 2900 | 10.11 |
| 12:06 ET | 15015 | 10.085 |
| 12:08 ET | 600 | 10.0738 |
| 12:10 ET | 1997 | 10.0714 |
| 12:12 ET | 1416 | 10.065 |
| 12:14 ET | 960 | 10.05 |
| 12:15 ET | 5500 | 10.04 |
| 12:17 ET | 5975 | 10.05 |
| 12:19 ET | 399 | 10.0271 |
| 12:21 ET | 4900 | 10.01 |
| 12:24 ET | 26370 | 9.97 |
| 12:26 ET | 950 | 10.01 |
| 12:28 ET | 125 | 9.9809 |
| 12:32 ET | 4503 | 9.93 |
| 12:33 ET | 1720 | 9.944 |
| 12:35 ET | 2684 | 9.97 |
| 12:37 ET | 15190 | 10.01 |
| 12:39 ET | 1135 | 10.0371 |
| 12:42 ET | 3700 | 10.0364 |
| 12:44 ET | 5773 | 10.0588 |
| 12:46 ET | 5727 | 10.13 |
| 12:48 ET | 2271 | 10.1679 |
| 12:50 ET | 2618 | 10.18 |
| 12:51 ET | 1986 | 10.1852 |
| 12:53 ET | 1055 | 10.2332 |
| 12:55 ET | 1300 | 10.26 |
| 12:57 ET | 500 | 10.27 |
| 01:00 ET | 601 | 10.28 |
| 01:02 ET | 10202 | 10.28 |
| 01:04 ET | 2510 | 10.31 |
| 01:06 ET | 4958 | 10.37 |
| 01:08 ET | 6193 | 10.27 |
| 01:09 ET | 220 | 10.26 |
| 01:13 ET | 3847 | 10.27 |
| 01:18 ET | 6208 | 10.25 |
| 01:20 ET | 900 | 10.25 |
| 01:22 ET | 1133 | 10.28 |
| 01:26 ET | 433 | 10.26 |
| 01:27 ET | 220 | 10.2315 |
| 01:29 ET | 3413 | 10.21 |
| 01:31 ET | 675 | 10.215 |
| 01:33 ET | 1100 | 10.22 |
| 01:36 ET | 1810 | 10.17 |
| 01:38 ET | 2254 | 10.16 |
| 01:40 ET | 800 | 10.135 |
| 01:42 ET | 1860 | 10.12 |
| 01:44 ET | 8521 | 10.08 |
| 01:45 ET | 9193 | 10.075 |
| 01:47 ET | 1533 | 10.09 |
| 01:49 ET | 2977 | 10.08 |
| 01:51 ET | 1778 | 10.13 |
| 01:56 ET | 100 | 10.13 |
| 01:58 ET | 3253 | 10.1042 |
| 02:00 ET | 2169 | 10.1 |
| 02:02 ET | 300 | 10.12 |
| 02:03 ET | 400 | 10.12 |
| 02:05 ET | 100 | 10.11 |
| 02:07 ET | 1418 | 10.14 |
| 02:09 ET | 600 | 10.165 |
| 02:12 ET | 4541 | 10.23 |
| 02:14 ET | 1350 | 10.205 |
| 02:16 ET | 300 | 10.19 |
| 02:18 ET | 302 | 10.1998 |
| 02:20 ET | 900 | 10.2 |
| 02:21 ET | 3344 | 10.18 |
| 02:25 ET | 184 | 10.205 |
| 02:27 ET | 1180 | 10.2265 |
| 02:30 ET | 6333 | 10.23 |
| 02:32 ET | 5641 | 10.24 |
| 02:34 ET | 1508 | 10.22 |
| 02:36 ET | 4274 | 10.22 |
| 02:38 ET | 446 | 10.215 |
| 02:39 ET | 200 | 10.215 |
| 02:41 ET | 2584 | 10.2 |
| 02:43 ET | 1221 | 10.175 |
| 02:45 ET | 2574 | 10.15 |
| 02:48 ET | 1703 | 10.14 |
| 02:50 ET | 4350 | 10.14 |
| 02:52 ET | 1903 | 10.1395 |
| 02:54 ET | 132 | 10.14 |
| 02:56 ET | 169 | 10.14 |
| 02:57 ET | 5500 | 10.13 |
| 02:59 ET | 6929 | 10.09 |
| 03:01 ET | 300 | 10.06 |
| 03:03 ET | 15387 | 9.98 |
| 03:06 ET | 1441 | 9.94 |
| 03:08 ET | 5477 | 9.98 |
| 03:10 ET | 4900 | 9.98 |
| 03:12 ET | 1597 | 9.948 |
| 03:14 ET | 100 | 9.94 |
| 03:15 ET | 6635 | 9.94 |
| 03:17 ET | 1578 | 9.98 |
| 03:19 ET | 1566 | 9.95 |
| 03:21 ET | 600 | 9.96 |
| 03:24 ET | 3274 | 9.975 |
| 03:26 ET | 2591 | 9.9968 |
| 03:28 ET | 6595 | 9.99 |
| 03:30 ET | 700 | 9.97 |
| 03:32 ET | 300 | 9.965 |
| 03:33 ET | 1804 | 9.96 |
| 03:35 ET | 9821 | 9.97 |
| 03:37 ET | 17829 | 9.99 |
| 03:39 ET | 205 | 9.9501 |
| 03:42 ET | 3108 | 9.945 |
| 03:44 ET | 8907 | 9.945 |
| 03:46 ET | 2488 | 9.945 |
| 03:48 ET | 5279 | 9.98 |
| 03:50 ET | 2360 | 9.97 |
| 03:51 ET | 2286 | 9.96 |
| 03:53 ET | 4072 | 9.97 |
| 03:55 ET | 2521 | 9.97 |
| 03:57 ET | 13219 | 9.98 |
| 04:00 ET | 95821 | 9.96 |
Nov 4, 2024
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
8:30AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones*DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow JonesCorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 626.8M | -12.4x | --- |
Zevra Therapeutics Inc | 487.3M | -4.9x | --- |
Elite Pharmaceuticals Inc | 659.9M | -106.0x | --- |
Cipla Ltd | 14.0B | 0.0x | --- |
Eton Pharmaceuticals Inc | 277.7M | -52.6x | --- |
Incannex Healthcare Inc | 34.8M | -1.4x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Chief Clinical Strategy and Operations Officer
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Legal Officer and Corporate Secretary
- Beth Kaufman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $626.8M |
|---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 60.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.57 |
EPS | $-0.80 |
Book Value | $1.28 |
P/E Ratio | -12.4x |
Price/Sales (TTM) | 51.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -415.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
